The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

HOUSSIAU, F.; VASCONCELOS, C.; D'CRUZ, D.; SEBASTIANI, G.; DE RAMON GARRIDO, E.; DANIELI, M.; Abramovicz, D.; BLOCKMANS, D.; CAULI, A.; Direskeneli, H.; GALEAZZI, M.; Guel, Ahmet; LEVY, Y.; PETERA, P.; POPOVIC, R.; PETROVIC, R.; SINICO, R.; CATTANEO, R.; FONT, J.; DEPRESSEUX, G.; COSYNS, J-P; CERVERA, R.

doi:10.1136/ard.2008.102533

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

Copy For Citation

HOUSSIAU F. A., VASCONCELOS C., D'CRUZ D., SEBASTIANI G. D., DE RAMON GARRIDO E., DANIELI M. G., ...More

ANNALS OF THE RHEUMATIC DISEASES, vol.69, no.1, pp.61-64, 2010 (SCI-Expanded)

Publication Type: Article / Article
Volume: 69 Issue: 1
Publication Date: 2010
Doi Number: 10.1136/ard.2008.102533
Journal Name: ANNALS OF THE RHEUMATIC DISEASES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.61-64
Istanbul University Affiliated: Yes

Abstract

Objective: To update the follow-up of the Euro-Lupus Nephritis Trial (ELNT), a randomised prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) cyclophosphamide (CY) followed by azathioprine (AZA) as treatment for proliferative lupus nephritis.